Immune Checkpoint Inhibitors As Potential Triggers for ANCA Vasculitis

Overview

Journal RMD Open

Publisher BMJ Publishing Group

Specialty Rheumatology

Date 2022 Aug 3

PMID 35922081

Authors

Faten Aqeel

Jose Monroy-Trujillo

Duvuru Geetha

Affiliations

Soon will be listed here.

Citing Articles

Immune checkpoint molecules performance in ANCA vasculitis.

Anton-Pampols P, Martinez Valenzuela L, Fernandez Lorente L, Quero Ramos M, Gomez Preciado F, Goma M RMD Open. 2024; 10(4).

PMID: 39537557 PMC: 11575324. DOI: 10.1136/rmdopen-2024-004660.

Immune checkpoint inhibitors and renal toxicity.

Bocchi F, Hafliger S, Schmid S, Sidler D Heliyon. 2024; 10(11):e31911.

PMID: 38841501 PMC: 11152715. DOI: 10.1016/j.heliyon.2024.e31911.

ANCA-Associated Vasculitis: Practical Issues in Management.

Roper T, Salama A Indian J Nephrol. 2024; 34(1):6-23.

PMID: 38645911 PMC: 11003588. DOI: 10.4103/ijn.ijn_346_23.

Identification of Immune-Related Genes as Biomarkers for Uremia.

Lyu D, He G, Zhou K, Xu J, Zeng H, Li T Int J Gen Med. 2023; 16:5633-5649.

PMID: 38050489 PMC: 10693762. DOI: 10.2147/IJGM.S435732.

Association between Loss of Immune Checkpoint Programmed Cell Death Protein 1 and Active ANCA-Associated Renal Vasculitis.

Hakroush S, Tampe B Int J Mol Sci. 2023; 24(3).

PMID: 36769297 PMC: 9918235. DOI: 10.3390/ijms24032975.

References

van den Brom R, Abdulahad W, Rutgers A, Kroesen B, Roozendaal C, de Groot D . Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition. Rheumatology (Oxford). 2016; 55(6):1143-5. DOI: 10.1093/rheumatology/kew063. View

Kitchlu A, Jhaveri K, Wadhwani S, Deshpande P, Harel Z, Kishibe T . A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease. Kidney Int Rep. 2021; 6(1):66-77. PMC: 7783581. DOI: 10.1016/j.ekir.2020.10.002. View

Walsh M, Merkel P, Peh C, Szpirt W, Puechal X, Fujimoto S . Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N Engl J Med. 2020; 382(7):622-631. PMC: 7325726. DOI: 10.1056/NEJMoa1803537. View

Nabel C, Severgnini M, Hung Y, Cunningham-Bussel A, Gjini E, Kleinsteuber K . Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer. Oncologist. 2019; 24(8):1013-1021. PMC: 6693726. DOI: 10.1634/theoncologist.2018-0633. View

Sibille A, Alfieri R, Malaise O, Detrembleur N, Pirotte M, Louis R . Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer. Front Oncol. 2019; 9:478. PMC: 6562339. DOI: 10.3389/fonc.2019.00478. View